Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach.
Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach.
复制标题
前列腺癌组织中的甲基化模式分析:使用 MS-MLPA 方法鉴定生物标志物。
DOI:
10.1186/s12967-016-1014-6
复制
发表时间:
2016-08-30
影响因子:
7.4
通讯作者:
Casadio V
中科院分区:
文献类型:
--
作者:
Gurioli G;Salvi S;Martignano F;Foca F;Gunelli R;Costantini M;Cicchetti G;De Giorgi U;Sbarba PD;Calistri D;Casadio V
Epigenetic silencing mediated by CpG island methylation is a common feature of many cancers. Characterizing aberrant DNA methylation changes associated with prostate carcinogenesis could potentially identify a tumour-specific methylation pattern, facilitating the early diagnosis of prostate cancer. The objective of the study was to assess the methylation status of 40 tumour suppressor genes in prostate cancer and healthy prostatic tissues. We used methylation specific-multiplex ligation probe amplification (MS-MLPA) assay in two independent case series (training and validation set). The training set comprised samples of prostate cancer tissue (n = 40), healthy prostatic tissue adjacent to the tumor (n = 26), and healthy non prostatic tissue (n = 23), for a total of 89 DNA samples; the validation set was composed of 40 prostate cancer tissue samples and their adjacent healthy prostatic tissue, for a total of 80 DNA samples. Methylation specific-polymerase chain reaction (MSP) was used to confirm the results obtained in the validation set. We identified five highly methylated genes in prostate cancer: GSTP1, RARB, RASSF1, SCGB3A1, CCND2 (P < 0.0001), with an area under the ROC curve varying between 0.89 (95 % CI 0.82–0.97) and 0.95 (95 % CI 0.90–1.00). Diagnostic accuracy ranged from 80 % (95 % CI 70–88) to 90 % (95 % CI 81–96). Moreover, a concordance rate ranging from 83 % (95 % CI 72–90) to 89 % (95 % CI 80–95) was observed between MS-MLPA and MSP. Our preliminary results highlighted that hypermethylation of GSTP1, RARB, RASSF1, SCGB3A1 and CCND2 was highly tumour-specific in prostate cancer tissue. The online version of this article (doi:10.1186/s12967-016-1014-6) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
8.8
作者:
Heijnsdijk, E. A. M.;der Kinderen, A.;Wever, E. M.;Draisma, G.;Roobol, M. J.;de Koning, H. J.
通讯作者:
de Koning, H. J.
影响因子:
7.5
作者:
Moelans, Cathy B.;de Groot, Jolien S.;van Diest, Paul J.
通讯作者:
van Diest, Paul J.
影响因子:
5.7
作者:
Hsu A;Wong CP;Yu Z;Williams DE;Dashwood RH;Ho E
通讯作者:
Ho E
影响因子:
14.9
作者:
Nygren AO;Ameziane N;Duarte HM;Vijzelaar RN;Waisfisz Q;Hess CJ;Schouten JP;Errami A
通讯作者:
Errami A
影响因子:
11.1
作者:
Brikun, Igor;Nusskern, Deborah;Freije, Diha
通讯作者:
Freije, Diha